Goldman Sachs Group Inc Applied Therapeutics Inc. Transaction History
Goldman Sachs Group Inc
- $555 Billion
- Q1 2024
A detailed history of Goldman Sachs Group Inc transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 715,208 shares of APLT stock, worth $3.06 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
715,208
Previous 16,752
4169.39%
Holding current value
$3.06 Million
Previous $56,000
8583.93%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding APLT
# of Institutions
100Shares Held
94MCall Options Held
5.83MPut Options Held
231K-
Franklin Resources Inc San Mateo, CA10.6MShares$45.2 Million0.02% of portfolio
-
Vr Adviser, LLC New York, NY9.08MShares$38.8 Million5.3% of portfolio
-
Perceptive Advisors LLC New York, NY8.01MShares$34.3 Million1.14% of portfolio
-
Janus Henderson Group PLC London, X06.41MShares$27.5 Million0.02% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA6.11MShares$26.2 Million24.19% of portfolio
About Applied Therapeutics Inc.
- Ticker APLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,020,700
- Market Cap $206M
- Description
- Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...